ACTRN12608000182392Completed未知
For patients who survive acute coronary syndrome does the availability of the CHOICE (Choice of health options in prevention of cardiovascular events) program improve the uptake of secondary prevention and reduce the proportion of patients with risk factors above national targets.
ANZAC Research Institute, Concord Hospital0 sites500 target enrollmentStarted: April 10, 2008Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 500
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
- Allocation
- Randomised controlled trial
- Primary Purpose
- Prevention
- Masking
- Blinded (masking used)
Eligibility Criteria
- Ages
- 18 Years to o limit (—)
- Sex
- All
Inclusion Criteria
- •Diagnosis of ACS in the four weeks prior to recruitment; refusal of the initial invitation to participate in standard CR; failure to attend initial CR assessment.
Exclusion Criteria
- •Clinical diagnosis of uncompensated, severe cardiac failure (Class IV); uncontrolled arrhythmia or angina; severe or symptomatic aortic stenosis; persistent hypotension (SBP < 90mmHg); clinical diagnosis of a severe coexisting medical condition that would prevent participation (eg, dementia, a terminal illness, severe rheumatoid arthritis); or insufficient English to provide written informed consent.
Investigators
Similar Trials
Suspended
Not Applicable
Medication Reviews ReDirected (MedReDi): Acute Coronary Syndrome as an Indication for Home Medicine Review, a Randomised Controlled TrialSecondary prevention of acute coronary syndromeCardiovascular - Coronary heart diseasePublic Health - Health service researchACTRN12611000452998nit for Medication Outcomes Research and Education, School of Pharmacy, University of Tasmania, Sandy Bay465
Recruiting
Not Applicable
Clinical Pathways for Acute Coronary Syndromes in China - phase 2: implementation and evaluatioAcute Coronary SyndromesCardiovascular - Coronary heart diseaseACTRN12609000491268Sanofi-Aventis (China)15,000
Completed
Phase 3
The Australian COPS trial - COlchicine in Patients with acute coronary SyndromesIschaemic heart diseaseCardiovascular - Coronary heart diseaseACTRN12615000861550St. Vincent's Hospital Melbourne800
Not yet recruiting
Not Applicable
Safe and effective early discharge of patients with low-risk coronary artery diseaseACTRN12613000200785Cardiology Department Eastern Health300
Not yet recruiting
Phase 4
Ticagrelor and platelet reactivity in acute coronary syndromesCardiovascular - Coronary heart diseaseAcute Coronary SyndromeACTRN12613001208796Peter Larsen50